Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Independent Market Research Ranks Sysmex in Hematology Instruments

By LabMedica International staff writers
Posted on 17 Mar 2009
In IMV's 2008 ServiceTrak annual report Sysmex America (Mundelein, IL, USA) was ranked best in hematology instrument reliability and industry for the ninth consecutive year. More...
Sysmex also ranked first in 21 of the 30 survey factors, including all five Original Equipment Manufacturer (OEM) service performance factors and all five manufacturer and instrument performance factors. The IMV ServiceTrak survey respondents include clinical laboratory department supervisors, laboratory managers, and technologists chosen at random from hospitals of varying sizes from across the country.

For customer satisfaction, Sysmex hematology instruments also ranked first in MD Buyline's January 2009 User Satisfaction Ratings. MD Buyline survey respondents include technologists and clinicians from hospitals and clinical reference laboratories located throughout the United States. MD Buyline is a comprehensive database of information on healthcare products.

"Regardless of the healthcare industry's economic concerns, we know our customers must provide high quality care for their patients. As a healthcare partner to many of the nation's healthcare facilities, we are honored that our hematology instruments have met their needs in reliability and performance expectations," said John Kershaw, president, Sysmex America, Inc.

Instrument reliability also impacts clinical laboratory performance metrics such as results turnaround time and repeat rate. Switching to backup analyzers could create issues with shifting normal ranges and consistency of results used in patient trending analysis. "Therefore, clinical laboratories will want to assess their instrument capability relative to their effect on service lines, care pathways, medical errors, and patient flow," added Mr. Kershaw.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), distributes and supports automated in vitro diagnostic hematology, coagulation, and urinalysis analyzers, reagents, and information systems for laboratories and healthcare facilities throughout the Western Hemisphere. The company focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide.

Related Links:

Sysmex America



New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.